Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Astrazeneca Plc (NY: AZN)
46.88 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 6:30 PM EST, Nov 11, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 0
Open 46.88
Bid (Size) 46.87 (3)
Ask (Size) 46.90 (8)
Prev. Close 46.88
Today's Range 46.88 - 46.88
52wk Range 35.30 - 49.22
Shares Outstanding 2,533,294,824
Dividend Yield 2.92%
Performance
YTD
+24.02%
+24.02%
1 Month
+6.93%
+6.93%
3 Month
+5.68%
+5.68%
6 Month
+25.75%
+25.75%
1 Year
+14.59%
+14.59%
Top News
More News
Roxadustat Phase III Program Pooled Analyses Showed Positive Efficacy and No Increased Cardiovascular Risk in Patients with Anemia from Chronic Kidney Disease Versus Comparators
AstraZeneca and FibroGen Inc. (FibroGen) today presented pooled efficacy and cardiovascular (CV) safety analyses from the pivotal Phase III program assessing roxadustat for the treatment of patients... Read More
from Business Wire News Releases
New Data From the Phase III DAPA-HF Trial Showed FARXIGA Reduced the Worsening of Heart Failure or Cardiovascular Death in HFrEF Patients With and Without Chronic Kidney Disease
AstraZeneca today announced a pre-specified sub-analysis from the landmark Phase III DAPA-HF trial investigating FARXIGA® (dapagliflozin) for the treatment of heart failure (HF). The data showed that... Read More
from Business Wire News Releases
More News
Read More
UPDATE 1-UK Stocks-Factors to watch on Nov 12
category companyNews
from Reuters: Company News
Roxadustat Significantly Increased Hemoglobin Levels for Chronic Kidney Disease Patients with Anemia in Phase III OLYMPUS and ROCKIES Trials
from Business Wire News Releases
AstraZeneca succeeds in treating lupus in late-stage study
category companyNews
from Reuters: Company News
Bulls And Bears Of The Week: Roku, Tesla, Twitter, Uber And More
category Trading Ideas , UBER , TWTR , and 8 more.
from Benzinga
NetworkNewsAudio – Predictive Oncology (NASDAQ: POAI) Subsidiary Leverages Extensive Molecular Information Platform to Accelerate New Drug Development
from NetworkNewsWire
NetworkNewsAudio – Predictive Oncology (NASDAQ: POAI) Subsidiary Leverages Extensive Molecular Information Platform to Accelerate New Drug Development
from InvestorBrandNetwork
Here’s Why FibroGen’s Stock Popped Friday
category AZN , AMGN , DVA , and 3 more.
from Motley Fool
UPDATE 1-Safety data on AstraZeneca anaemia drug points to potential use in dialysis
category companyNews
from Reuters: Company News
Week in Review: AstraZeneca Announces $1 Billion Fund for China Life Science Startups
from ChinaBio® Today
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
X